Invesco’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-155,673
| Closed | -$939K | – | 3813 |
|
|
2019
Q4 | $939K | Sell |
155,673
-44,255
| -22% | -$256K | ﹤0.01% | 3025 |
|
|
2019
Q3 | $720K | Buy |
199,928
+40,250
| +25% | +$155K | ﹤0.01% | 3136 |
|
|
2019
Q2 | $428K | Sell |
159,678
-5,482
| -3% | -$16.2K | ﹤0.01% | 3375 |
|
|
2019
Q1 | $489K | Sell |
165,160
-24,570
| -13% | -$60.4K | ﹤0.01% | 3323 |
|
|
2018
Q4 | $302K | Buy |
189,730
+47,539
| +33% | +$134K | ﹤0.01% | 3463 |
|
|
2018
Q3 | $523K | Buy |
142,191
+21,169
| +17% | +$63.1K | ﹤0.01% | 3411 |
|
|
2018
Q2 | $342K | Buy |
121,022
+1,444
| +1% | +$4.92K | ﹤0.01% | 3557 |
|
|
2018
Q1 | $444K | Buy |
119,578
+21,179
| +22% | +$69.3K | ﹤0.01% | 3373 |
|
|
2017
Q4 | $283K | Buy |
98,399
+6,611
| +7% | +$24K | ﹤0.01% | 3461 |
|
|
2017
Q3 | $412K | Buy |
91,788
+1,347
| +1% | +$5.98K | ﹤0.01% | 3365 |
|
|
2017
Q2 | $415K | Sell |
90,441
-1,092
| -1% | -$4.39K | ﹤0.01% | 3378 |
|
|
2017
Q1 | $385K | Buy |
+91,533
| New | +$380K | ﹤0.01% | 3425 |
|
|
2016
Q4 | – | Sell |
-799,847
| Closed | -$6.48M | – | 3731 |
|
|
2016
Q3 | $6.48M | Buy |
799,847
+23,654
| +3% | +$201K | ﹤0.01% | 1807 |
|
|
2016
Q2 | $6.05M | Sell |
776,193
-261,258
| -25% | -$2.24M | ﹤0.01% | 1785 |
|
|
2016
Q1 | $8.01M | Sell |
1,037,451
-88,998
| -8% | -$652K | ﹤0.01% | 1536 |
|
|
2015
Q4 | $12.2M | Buy |
1,126,449
+1,114,785
| +9,557% | +$10.1M | ﹤0.01% | 1392 |
|
|
2015
Q3 | $81K | Buy |
11,664
+7,809
| +203% | +$63.6K | ﹤0.01% | 3700 |
|
|
2015
Q2 | $34K | Sell |
3,855
-1,722,981
| -100% | -$16.3M | ﹤0.01% | 4009 |
|
|
2015
Q1 | $17M | Buy |
1,726,836
+319,076
| +23% | +$3.98M | 0.01% | 1278 |
|
|
2014
Q4 | $17.2M | Buy |
1,407,760
+121,087
| +9% | +$1.48M | 0.01% | 1244 |
|
|
2014
Q3 | $12.8M | Buy |
1,286,673
+824,276
| +178% | +$7.65M | 0.01% | 1400 |
|
|
2014
Q2 | $3.5M | Buy |
+462,397
| New | +$1.84M | ﹤0.01% | 2219 |
|
Invesco's ACHN Position: Q1 2020 in Review
Invesco sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 155,673 shares — an estimated $939K sold.
Invesco first reported a position in ACHN in Q2 2014 and held it in 22 quarters. The position peaked at $17.2M in Q4 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Invesco reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Invesco sold 155,673 Achillion Pharmaceuticals shares in Q1 2020, an estimated $939K.
- Invesco first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 22 quarters.
- Invesco's Achillion Pharmaceuticals position peaked at $17.2M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Invesco's 13F filing for Q1 2020, filed 15 May 2020.